Gene and Cell Therapy: Development and Commercialization Summit
26-27

February 2019

Austria

Vienna

Сo-located with 2nd Annual Orphan Drugs Summit

We are pleased to invite you to the Annual Gene and Cell Therapy Summit: Development and Commercialization, scheduled for February 26 - 27, 2019 in Vienna, Austria. This premier B2B event provides the appropriate platform to engage and discuss ideas with your fellow peers, while facilitating a professional atmosphere and environment for good company representation and development. The summit will shed light on the delivery of cost and quality efficient process development, manufacturing, and commercialization of cell and gene therapies. It i...

We are pleased to invite you to the Annual Gene and Cell Therapy Summit: Development and Commercialization, scheduled for February 26 - 27, 2019 in Vienna, Austria. This premier B2B event provides the appropriate platform to engage and discuss ideas with your fellow peers, while facilitating a professional atmosphere and environment for good company representation and development. The summit will shed light on the delivery of cost and quality efficient process development, manufacturing, and commercialization of cell and gene therapies. It is an honour and privilege to invite you to participate in this Summit. We look forward to welcoming you in Vienna in February!

more info
Who Should Attend

Chief Executives, Vice Presidents, Directors, Heads, Leaders, and Managers specialising in:

  • Advanced Therapy Production
  • Bioprocessing
  • CAR-T
  • Cell Therapy
  • Cellular Therapy
  • CMC
  • GMP
  • Immune Deficiencies
  • Immunology
  • Immunotherapy
  • Manufacturing
  • Medical
  • Precision Medicine
  • Process Development
  • R&D
  • Regulatory
  • Stem Cell
  • Tissue Therapy
  • Analytical
  • Biotherapeutics
  • Cell Engineering
  • Cellular Immunotherapy
  • Clinical Development
  • Gene Therapy
  • Health Economics
  • Immuno-Oncology
  • Immunology Chemistry
  • Legal/IP
  • Market Access
  • Oncology
  • Pricing
  • Quality Control
  • Regenerative Medicine
  • Sales
  • Supply Chain
Key Practical Learning Points of the Summit

Optimized cell and gene therapies process development, manufacturing, cost, and quality efficiency
Emerging science and technologies to enhance cell and gene therapies development
Advanced analytical approaches to improve quality control and real time release
Regulatory compliance to empower development and commercialization strategies of cell and gene therapies
Robust supply chain design for precision medicine therapies